评估新诊断的儿科癌症儿童的诊断间隔:一个横截面研究
Monisha Manoharan1, Sanjeev Khera2, Aparajita Gupta3
1Junior Resident (Paediatrics), Army Hospital (Research & Referral), New Delhi, India.
Medical journal, Armed Forces India
|October 6, 2025
概括
在低收入和中等收入国家 (LMICs) 诊断儿童癌症的重大延迟导致死亡率. 医生推延迟是主要原因,强调需要提高认识,以改善儿科癌症的结果.
科学领域:
- 儿科瘤学 儿科瘤学
- 全球健康 全球健康
- 癌症流行病学 癌症流行病学
背景情况:
- 儿科癌症的诊断延迟 (DI) 是死亡的一个关键因素,特别是在低收入和中等收入国家 (LMICs).
- 关于LMICs的DI及其贡献因素的数据有限,阻碍了有针对性的干预.
研究的目的:
- 评估诊断间隔 (DI) 并确定影响儿童癌症诊断延迟的因素.
- 分析患者间隔 (PI) 和治疗间隔 (TI) 与DI结合.
主要方法:
- 一项涉及120名怀疑或确诊患有恶性瘤的12岁以下儿童的横截面研究.
- 排除标准包括先前的化疗,诊断前的死亡和良性瘤.
- 通过使用定制问卷采访护理人员收集的数据.
主要成果:
- 在79名被分析的儿童中,DI的中位数为17天,其中41.8%的儿童经历了长时间的DI (>30天).
- 医生推延迟是整体延迟的主要原因 (总延迟的中位数为74天).
- 替代药物的试验是与长时间的DI (OR=6.24) 相关的唯一显著因素.
结论:
- 在LMICs中,儿科癌症诊断和管理的实质性延迟仍然存在.
- 提高医生和家长的认识对于减轻诊断延迟和改善癌症儿童的治疗结果至关重要.
更多相关视频
05:56Implementation of Non-invasive Point of Care Transient Elastography for Evaluation of Liver Disease in Pediatric Populations with Cystic Fibrosis
Published on: August 29, 2025
437
09:44Pretargeted Radioimmunotherapy Based on the Inverse Electron Demand Diels-Alder Reaction
Published on: January 29, 2019
10.5K
相关概念视频
Cancer Survival Analysis
645
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
645
Pharmacokinetics in Pediatric Patients: Drug Excretion
212
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
212
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
242
Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
242
